2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

Changes in handwriting following repetitive transcranial magnetic stimulation over pre-motor cortex in Parkinson’s disease

A.Y. Son, M.C. Biagioni, E. Pirraglia, A. DiRocco (New York, NY, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Changes of speech after neurostimulation for Parkinson’s disease with early fluctuations: A 2-years randomized controlled trial (earlystim-speech)

S. Pinto, A. Nebel, R. Espesser, J. Rau, P. Maillochon, O. Krack, K. Knudsen, A. Ghio, O. Niebuhr, Y. Agid, M. Schüpbach, G. Deuschl (Aix-en-Provence, France)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Characterization of European longitudinal cohort studies in Parkinson’s disease – Report of the JPND working group BioLoC-PD

S. Lerche, I. Liepelt-Scarfone, G. Alves, P. Barone, S. Behnke, Y. Ben-Shlomo, H. Berendse, D. Burn, R. Dodel, D. Grosset, M. Hu, M. Kasten, R. Krüger, W. Maetzler, B. Mollenhauer, W. Oertel, U. Walter, K. Wirdefeldt, D. Berg (Tübingen, Germany)

Other  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Chewing-induced blepharospasm in Parkinson’s disease

E. Sasse, L.F. Vasconcellos, M. Spitz (Rio de Janeiro, Brazil)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Classification and recommendation of nonpharmacological therapies for Parkinson’s disease

T.T.C. Capato, C.H. Fen, E.R. Barbosa (São Paulo, Brazil)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Clinical and biological predictors of time to initiation of symptomatic therapy in early Parkinson’s disease

T. Simuni, J. Long, C. Caspell-Garcia, C.S. Coffey, S. Lasch, C. Tanner, D. Jennings, K. Kieburtz, K. Marek, On behalf of the PPMI Investigators (Chicago, IL, USA)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Clinical and molecular features of DYT1 primary dystonia in a Peruvian population

M. Inca-Martinez, K. Milla-Neyra, C.C. Cosentino, N. Mori, V. Marca, M. Flores, E. Guevara-Silva, Y. Nuñez-Coronado, C.M. Vasquez, L. Torres-Ramirez, P. Mazzetti, M. Cornejo-Olivas (Lima, Peru)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Clinical benefits of vestibular rehabilitation in neurodegenerative diseases

B.S. Zeigelboim, G.B. Santos, H.A.G. Teive, M.I.R. Severiano, C.M. Porto (Curitiba, Brazil)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Clinical characteristics and natural history of oromandibular dystonia

L. Scorr, S. Factor, H. Jinnah (Atlanta, GA, USA)

Dystonia and Pediatric Movement Disorders

12:00pm-1:30pm

Clinical characterization of pramipexole induced edema in Parkinson’s disease (PD). Is it always the best option discontinue the treatment?

E. Urrea-Mendoza, F.J. Revilla (Greenville, SC, USA)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2